Cancer Research

Published by: American Association for Cancer Research  

People

  1. Patil
    Patil
  2. Goldfarb
    Goldfarb
  3. Hudis
    Hudis
  4. Dickler
    Dickler
  5. Dang
    Dang
  6. Modi
    Modi
  7. Norton
    Norton
  8. Lake
    Lake
  9. Baselga
    Baselga
  10. Blinder
    Blinder

Groups

  1. Biostatistics Service (18)
  2. Breast Medicine Service (18)
  3. Department of Medicine (18)
  4. Epidemiology and Biostatistics (18)
  5. Population Sciences Research Program (18)
  6. Solid Tumor Oncology Division (18)
  7. Survivorship Research (17)
  8. Health Outcomes Research Group (9)
  9. Psychiatry and Behavioral Sciences, Department of (9)
  10. Division of Subspecialty Medicine (8)
Search Within
  1. "Population Sciences Research Program"
  2. "Sujata Patil"
Formats
  1. Meeting Abstract (18)
Groups
  1. Biostatistics Service (18)
  2. Breast Medicine Service (18)
  3. Department of Medicine (18)
  4. Epidemiology and Biostatistics (18)
  5. Population Sciences Research Program (18)
  6. Solid Tumor Oncology Division (18)

More Groups

People
  1. Sujata Patil (18)
  2. Clifford Hudis (9)
  3. Shari Goldfarb (9)
  4. Maura Dickler (7)
  5. Chau Dang (6)
  6. Larry Norton (6)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2019 (3)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publishers
  1. American Association for Cancer Research (18)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pregnancy-associated breast cancer: Does timing of presentation affect outcome?
    Meeting Abstract

    Crown, A.; McCartan, D.; Curry, M.; Feldman, M.; Patil, S.; Kamer, S.; Goldfarb, S. B.; Gemignani, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Patil, S.; Norton, L.; Robson, M.; Dang, C.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A pilot randomized usual care controlled study of yoga for persistent chemotherapy-induced peripheral neuropathy (CIPN) in breast and gynecological cancer survivors
    Meeting Abstract

    Zhi, W. I.; Leeolou, M. C.; Piulson, L.; Chen, P.; Patterson, C.; Paul, T.; Patil, S.; Mao, J. J.; Bao, T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • The CHANCE study: Mechanical skin changes among women with non-metastatic breast cancer receiving chemotherapy and endocrine therapy
    Meeting Abstract

    Lacouture, M. E.; Phillips, G. S.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Kukoyi, O.; Goldfarb, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Chemotherapy-induced peripheral neuropathy in breast cancer survivors: Comparison of objective and subjective measures
    Meeting Abstract

    Bao, T.; Kwon, A.; Piulson, L.; Chen, P.; Li, Q.; Patil, S.; Seidman, A.; Blinder, V.; Vahdat, L.; Zhi, W. I.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
    Meeting Abstract

    Argolo, D.; Friedman, M.; Smyth, L.; Iyengar, N.; Singh, J.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research